How We Decide Whether a New Therapy Belongs in Our Clinic

Every month, someone emails me about a treatment I've never heard of. A vendor, a conference rep, a patient who read about it on a podcast. The pitch is always some version of the same thing: this one's different, the early results are incredible, you'd be crazy not to offer it. I'm a hospitalist by day, so I've sat through plenty of these pitches. And I've learned that the louder the pitch, the slower I should walk.

I'm Dr. Farhan Abdullah, and the clinic I run, Magnolia Functional Wellness in Southlake, doesn't add a therapy because it's trendy or because the margin looks good. It gets added after it clears a set of questions I've been refining for years. I figured you'd want to see them. If you're a patient, it'll help you judge any clinic, ours included. If you're a colleague, argue with me.

By Dr. Farhan Abdullah, DO | Medical Director, Magnolia Functional Wellness | Southlake, TX

Start With What Medicine Actually Means by Evidence

Back in 1996, David Sackett and his colleagues wrote a short, famous piece in the BMJ, Evidence based medicine: what it is and what it isn't. Their point still holds up. Good practice blends the best available research with the clinician's own experience and the patient's values. Take away any one leg and the stool tips over. A study without clinical judgment can mislead you. Clinical judgment without a study is just a strong opinion.

That framing shapes my first filter. When something new lands on my desk, I ask what kind of evidence stands behind it. A randomized trial in people, with a control group, published in a peer-reviewed journal? Great. A handful of case reports and a testimonial reel? That's a story, not data. Stories matter, they tell us where to look, but they don't earn a spot in my exam room.

I also want to know who ran the study and who paid for it. Industry-funded research isn't automatically bad. A lot of the drugs I prescribe in the hospital exist because a company bankrolled the trials. But funding changes how hard I squint at the design, the endpoints, and the way the results got spun in the press release.

Why I Distrust the First Exciting Result

There's a paper every physician should read once a year, John Ioannidis's essay in PLoS Medicine, Why most published research findings are false. It's provocative on purpose. His argument is that small studies, flexible analyses, and hot, crowded fields produce a lot of results that don't hold up when someone repeats them.

You don't have to accept every line of it to take the lesson. A single small trial with a dramatic effect is a reason to be interested, not a reason to change practice. I want to see the finding repeated by a different group, in a different population, ideally with a larger sample. Medicine has a long history of reversals, treatments that looked wonderful early and then faded or got abandoned once better data arrived. I don't want my patients to be the ones who find out.

So when a rep tells me a therapy has "promising early data," I translate that. It means the story isn't finished. Sometimes the right move is to wait a year and watch what happens. Waiting isn't timid. It's cheaper than apologizing.

The Five Questions We Ask Before Anything Goes on the Menu

Here's the actual checklist. It isn't fancy, and I don't pretend it's a validated instrument. It's the thing I run through, usually on a legal pad, before I say yes.

• Is there human evidence for the condition we'd treat? Animal data and cell studies are where ideas begin. They're not where decisions end.
• Does the product have a clear regulatory status? I want to know exactly what it is, who makes it, how it's classified, and what it's legally allowed to be used for. If nobody can answer that cleanly, I stop.
• Can I measure whether it's working? If there's no lab value, symptom score, or functional test to track, I can't tell you whether you're improving or just hopeful.
• What happens if it goes wrong? I want to know the side effects, who shouldn't take it, and how we'd manage a bad reaction at 9 p.m. on a Sunday.
• Would I be comfortable explaining it to my own family? This one sounds soft, but it's the filter that catches the most. If I'd hesitate to recommend it to my mother, it doesn't belong here.

A therapy that passes four of five still doesn't make the cut. Not three of five, not four. Every one has to hold, because the failures cluster. Products with fuzzy regulatory status usually also have fuzzy evidence, and the lack of a way to measure results usually travels with a sales pitch that leans on feelings.

The Difference Between Interesting and Ready

I get asked a lot why Magnolia doesn't offer every new thing in the wellness space. Patients see another clinic advertising something and wonder if we're behind. We're not behind. We're picky.

Plenty of ideas are interesting. Few are ready. Interesting means a plausible mechanism and a few encouraging signals. Ready means the evidence, the sourcing, the monitoring, and the safety net are all in place. I've watched clinics rush a service onto the menu because a competitor had it, then scramble when patients started asking hard questions the staff couldn't answer. I'd rather lose a sale than lose a patient's trust.

That's also why you'll find our program built around a smaller set of services that we know well. Weight management with medications that have extensive trial data behind them. Hormone care that starts with labs and gets rechecked. Regenerative and orthopedic options we describe honestly, including where the research is thin. When we talk through peptide medication therapy, for instance, the conversation starts with what's been studied, in whom, and what the limits are. The same goes for the physician-supervised approach we outline in our GLP-1 guide for the DFW area.

And yes, some things we've looked at and said no to. That list is longer than the list of what we offer. I don't say that to brag. It's just how the filter works when you apply it honestly.

What Happens After We Say Yes

Approval isn't the finish line. Once something joins the clinic, we keep checking it. Are patients improving on the measures we chose? Are we seeing side effects we didn't expect? Has new research changed the picture? A therapy that earned its place in 2024 doesn't get a free pass in 2026.

That sometimes means pulling back. If new data weakens the case, or a regulatory change shifts the ground, we adjust, and we tell patients plainly why. I've had those conversations, and they're uncomfortable. They're also the whole point of being a physician rather than a retailer.

It also means I keep my own bias in check. Functional medicine training taught me to look for root causes and to think about the whole person, and I value that. But a good framework doesn't excuse weak evidence. If anything, it raises the bar, because it's easy to build a convincing story around a patient's symptoms and then sell a product that fits it.

How You Can Use This as a Patient

You don't need a medical degree to run a version of this checklist on any clinic. Ask what the treatment is, exactly, and who manufactures it. Ask what studies support it and whether they were done in people like you. Ask how you'll know if it's working and what the plan is if it isn't. Ask what the side effects are and who to call.

Watch how the answers land. A clinician who welcomes the questions, who says "good question, here's what we know and here's what we don't," is a good sign. If you get defensiveness, jargon, or a quick pivot to pricing, take note. Hard questions are a normal part of good care, not an insult.

One more thing. Be wary of anyone who promises certainty. Real medicine deals in probabilities, trade-offs, and individual variation. Even the best-supported treatments don't work for everybody, and honest clinicians will say so up front.

At Magnolia Functional Wellness, we'll keep saying no more often than people expect. If you're in Southlake or anywhere around Dallas-Fort Worth and you'd like to talk through whether a treatment you've been reading about makes sense for you, bring your questions. The tougher, the better.